Ashton Thomas Private Wealth, LLC Xenon Pharmaceuticals Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $1.83 Trillion
- Q2 2024
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 135 shares of XENE stock, worth $5,412. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135Holding current value
$5,412% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
69.6MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$227 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$177 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$153 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$110 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$108 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.5B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...